Israel - English - Ministry of Health

rafa laboratories ltd - netupitant; palonosetron as hydrochloride - capsules - netupitant 300 mg; palonosetron as hydrochloride 0.50 mg - palonosetron, combinations - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy.

European Union - English - EMA (European Medicines Agency)

helsinn birex pharmaceuticals ltd. - palonosetron hydrochloride - vomiting; cancer - antiemetics and antinauseants, , serotonin (5ht3) antagonists - aloxi is indicated in adults for:the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy,the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy.aloxi is indicated in paediatric patients 1 month of age and older for:the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy and prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy.

European Union - English - EMA (European Medicines Agency)

helsinn birex pharmaceuticals ltd. - chlormethine - mycosis fungoides - antineoplastic agents - ledaga is indicated for the topical treatment of mycosis fungoides-type cutaneous t-cell lymphoma (mf-type ctcl) in adult patients.

Israel - English - Ministry of Health

rafa laboratories ltd - chlormethine as hydrochloride - gel - chlormethine as hydrochloride 160 mcg/g - chlormethine - topical treatment of stage ia and ib mycosis fungoides-type cutaneous t-cell lymphoma in patients who have received prior skin-directed therapy

Israel - English - Ministry of Health

rafa laboratories ltd - palonosetron as hydrochloride - capsules - palonosetron as hydrochloride 0.5 mg - palonosetron - paloxi is indicated in adult for the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy.

Ireland - English - HPRA (Health Products Regulatory Authority)

helsinn birex pharmaceuticals limited - macrogol 3350 - powder for oral solution - 5.9 gram(s) - osmotically acting laxatives; macrogol, combinations

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

helsinn birex pharmaceuticals ltd, ireland - netupitant,palonosetron hydrochloride - capsule, hard - 300,0.5 mg,

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

helsinn birex pharmaceuticals ltd. - bicarbonato - bicarbonato....20 mmol/l / sulfato de sodio anhidro ....5.685 g / sulfato....40 mmol/l / potasio....10 mmol/l / cloruro de potasio....0.7425g / polietilenglicol 3350 u.sn.f....59 g / bicarbonato de sodio ....1.685 g / sodio....125 mmol/l / cloruro de sodio....1.465 g / cloruro....35 mmol/l

European Union - English - EMA (European Medicines Agency)

helsinn birex pharmaceuticals ltd - netupitant, palonosetron hydrochloride - vomiting; neoplasms; nausea; cancer - antiemetics and antinauseants, - akynzeo is indicated in adults for the:prevention of acute and delayed nausea and vomiting associated with highly emetogenic cisplatin based cancer chemotherapy.prevention of acute and delayed nausea and vomiting associated with moderately emetogenic cancer chemotherapy.

Ireland - English - HPRA (Health Products Regulatory Authority)

helsinn birex pharmaceuticals limited - sodium chloride; potassium chloride; macrogol 3350; sodium bicarbonate; sodium sulfate anhydrous - powder for oral solution - per cent - osmotically acting laxatives; macrogol, combinations